Healthcare
Live Price
Offline$0.98
-8.41% today
1Y Change
-88.05%
Window
Jun 20, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 20, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Revelation Biosciences, Inc. (REVB) is a Healthcare stock with listed on NASDAQ. The stock last traded around $0.98 and down 88.0% across the available one-year price window (Jun 20, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +72.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +72.7%, free cash flow +54.9% with operating margin 0.0% and ROIC -94.4%. Stock Foundry combines REVB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
REVB
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
REVB Max Drawdown
-92.23%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for REVB and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.